Disorders of Lipid Metabolism and its Correction in Chronic Kidney Disease
Journal Title: Нирки - Year 2016, Vol 2, Issue 16
Abstract
Chronic kidney disease — a proven risk factor of the development and progression of lipid metabolism disorders. The basis of these disorders — an increase in blood plasma cholesterol, triglycerides, low density lipoproteins and decreased levels of high density lipoproteins, apo AI and apo AII. There has been a decrease in the activity of enzymes: lipoprotein lipase, hepatic triglyceride lipase, lecithin-cholesterol acyltransferase. The use of lipid-modifying drugs — statins, fibrates, nicotinic acid was proposed.
Authors and Affiliations
O. O. Melnyk
Keywords
Related Articles
- EP ID EP208383
- DOI -
- Views 103
- Downloads 0
Resistance of bacteria isolated in urinary tract infections to antimicrobial drugs in children
Background. Urinary tract infection (UTI) is one of the main causes of hospitalization of children. One of the main causes of ineffective treatment of UTI in children is the antibiotic resistance of UTI pathogens. The pu...
Modern Philosophy of Knowledge Transfer in Postgraduate Medical Education
.
Guideline Summary KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update
Guideline Summary "KDOQI clinical practice guideline for hemodialysis adequacy", 2015 update
Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45 ml/min/1.73 m2) European renal best practice
.
Hypomagnesemia in Chronic Kidney Disease: Problem or Individual Characteristics of Certain Patients?
The article considers the problem of magnesium deficiency in patients with chronic kidney disease. It requires special attention from clinicians due to the increased risk of cardiovascular complications. The study reveal...